Farmaceutica R (RMAH) - Total Assets
Based on the latest financial reports, Farmaceutica R (RMAH) holds total assets worth RON345.32 Million RON (≈ $79.29 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see RMAH market cap for the company's overall valuation and market capitalisation.
Farmaceutica R - Total Assets Trend (2020–2025)
This chart illustrates how Farmaceutica R's total assets have evolved over time, based on quarterly financial data. See RMAH share price today for real-time trading data and today's change.
Farmaceutica R - Asset Composition Analysis
Current Asset Composition (September 2025)
Farmaceutica R's total assets of RON345.32 Million consist of 86.5% current assets and 13.5% non-current assets. Explore Farmaceutica R working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (RON) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RON0.00 | 15.1% |
| Accounts Receivable | RON205.04 Million | 53.5% |
| Inventory | RON63.37 Million | 16.5% |
| Property, Plant & Equipment | RON0.00 | 0.0% |
| Intangible Assets | RON1.45 Million | 0.4% |
| Goodwill | RON0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Farmaceutica R's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Farmaceutica R's current assets represent 86.5% of total assets in 2025, an increase from 83.5% in 2020.
- Cash Position: Cash and equivalents constituted 15.1% of total assets in 2025, up from 14.1% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 53.5% of total assets.
Farmaceutica R Competitors by Total Assets
Key competitors of Farmaceutica R based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥112.28 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Quipt Home Medical Corp
NASDAQ:QIPT
|
USA | $202.55 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
Farmaceutica R - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.10 | 1.11 | 1.13 |
| Quick Ratio | 0.91 | 0.91 | 0.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RON27.16 Million | RON31.88 Million | RON27.12 Million |
Farmaceutica R - Advanced Valuation Insights
This section examines the relationship between Farmaceutica R's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.94 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 2.2% |
| Total Assets | RON383.19 Million |
| Market Capitalization | $15.92 Million USD |
Valuation Analysis
Below Book Valuation: The market values Farmaceutica R's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Farmaceutica R's assets grew by 2.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Farmaceutica R (2020–2025)
The table below shows the annual total assets of Farmaceutica R from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | RON383.19 Million ≈ $87.99 Million |
+2.17% |
| 2024-09-30 | RON375.04 Million ≈ $86.11 Million |
+18.77% |
| 2023-09-30 | RON315.76 Million ≈ $72.50 Million |
+10.33% |
| 2022-09-30 | RON286.20 Million ≈ $65.72 Million |
+13.99% |
| 2021-09-30 | RON251.07 Million ≈ $57.65 Million |
+2.70% |
| 2020-09-30 | RON244.46 Million ≈ $56.13 Million |
-- |
About Farmaceutica R
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics and warehousing, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 199… Read more